Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chinese Medical Journal

• Publication date

  2009-05-20

• Fields of study

  Medicine

• Identifiers
  PMID 19493461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells

  2008cited by this paper
• Protective Effects of Aspirin Against Oxidized LDL-induced Inflammatory Protein Expression in Human Endothelial Cells

  2008cited by this paper
• Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injury

  2008cited by this paper
• Chemokine Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood: A Critical Role for P-Selectin Expressed on Activated Platelets

  2007cited by this paper
• Role of Inflammation in Atherosclerosis*

  2007cited by this paper
• Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome.

  2007cited by this paper
• Cytokines in atherosclerosis: pathogenic and regulatory pathways.

  2006cited by this paper
• Effects of aspirin on atherosclerosis and the cyclooxygenase-2 expression in atherosclerotic rabbits.

  2006cited by this paper
• Stronger inhibition by nonsteroid anti‐inflammatory drugs of cyclooxygenase‐1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events

  2006cited by this paper
• Relevance of platelet-independent effects of aspirin to its salutary effect in atherosclerosis-related events.

  2005cited by this paper
• Nuclear factor kappaB signaling in atherogenesis.

  2005cited by this paper
• Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease

  2004cited by this paper
• Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.

  2004cited by this paper
• Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells.

  2004cited by this paper
• Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice

  2003cited by this paper
• Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study

  2003cited by this paper
• Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

  2003cited by this paper
• Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

  2003cited by this paper
• Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.

  2003cited by this paper
• Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease.

  2002cited by this paper
• Cyclooxygenase-2 and atherosclerosis

  2002cited by this paper
• Roles of Cyclooxygenase (COX)-1 and COX-2 in Prostanoid Production by Human Endothelial Cells: Selective Up-Regulation of Prostacyclin Synthesis by COX-21

  2001cited by this paper
• Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic Lesions

  2001cited by this paper
• Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

  2001cited by this paper
• Fractalkine and vascular injury.

  2001cited by this paper
• Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

  2001cited by this paper
• NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS.

  2000cited by this paper
• Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells.

  2000cited by this paper
• Chemokines, leukocytes, and atherosclerosis.

  2000cited by this paper
• Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

  1998cited by this paper
• A new class of membrane-bound chemokine with a CX3C motif

  1997cited by this paper
• Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells.

  1995cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper

• Beneficial effects of combined administration of Clopidogrel and Aspirin on the levels of proinflammatory cytokines, cardiac function, and prognosis in ST-segment elevation myocardial infarction

  2018cites this paper
• Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes*

  2018cites this paper
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways.

  2016cites this paper
• Placental fractalkine is up-regulated in severe early-onset preeclampsia.

  2015cites this paper
• Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways

  2015cites this paper
• Fractalkine and Its Receptor (CX3CR1) in Patients with Stable Coronary Artery Disease and Diabetes Mellitus

  2012cites this paper
• Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions

  2012cites this paper
• Detrimental effect of fractalkine on myocardial ischaemia and heart failure.

  2011cites this paper
• Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

  2010cites this paper